Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Receivables - Other: 2016-2017

Historic Receivables - Other for KalVista Pharmaceuticals (KALV) over the last 2 years, with Apr 2017 value amounting to $297,000.

  • KalVista Pharmaceuticals' Receivables - Other was N/A to $73,000 in Q3 2017 from the same period last year, while for Jul 2017 it was $73,000, marking a year-over-year change of. This contributed to the annual value of $297,000 for FY2017, which is 16.57% down from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Receivables - Other stood at $297,000 for FY2017, which was down 16.57% from $356,000 recorded in FY2016.
  • KalVista Pharmaceuticals' Receivables - Other's 5-year high stood at $356,000 during FY2016, with a 5-year trough of $297,000 in FY2017.
  • In the last 2 years, KalVista Pharmaceuticals' Receivables - Other had a median value of $326,500 in 2016 and averaged $326,500.
  • Data for KalVista Pharmaceuticals' Receivables - Other shows a maximum YoY fell of 16.57% (in 2017) over the last 5 years.
  • Yearly analysis of 2 years shows KalVista Pharmaceuticals' Receivables - Other stood at $356,000 in 2016, then declined by 16.57% to $297,000 in 2017.